TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MNOV

MediciNova Inc

Healthcare · Biotechnology

3.50$ +36.9% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns MediciNova Inc (MNOV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.8% of the shares are freely tradable; institutional investors hold 11.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 11.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 85.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 49Mio.

Largest Shareholders

Institutions

Institutions MNOV
Name Stake (%) Shares Change (%) Date
Essex Woodlands Health Ventures 2.25 1,105,941 +0.0 06/30/2026
BlackRock Inc 1.43 705,954 +0.1 03/31/2026
Citigroup Inc 1.29 635,715 +0.0 03/31/2026
Vanguard Capital Management, LLC 1.24 611,039 +0.0 03/31/2026
Geode Capital Management, LLC 1.10 543,843 +2.7 03/31/2026
Vanguard Fiduciary Trust Co 0.57 280,621 +0.0 03/31/2026
UBS Group AG 0.45 222,200 -1.5 03/31/2026
State Street Corp 0.39 193,698 +0.0 03/31/2026

Funds

Funds MNOV
Name Stake (%) Shares Change (%) Date
Vanguard Institutional Extnd Mkt Idx Tr 1.24 609,052 +0.0 07/31/2026
Fidelity Extended Market Index 0.51 251,205 -0.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?